<ul><li>Stereotaxis Inc. announced that its Genesis surgical robot has received regulatory approval in China.</li><li>The Genesis RMN System delivers safe and precise cardiac ablation to treat arrhythmias.</li><li>China's National Medical Products Administration (NMPA) granted the approval to Stereotaxis and Shanghai MicroPort EP Medtech Co. for the Genesis robotic magnetic navigation (RMN) system.</li><li>MicroPort EP plans to begin a full launch of Genesis through existing sales teams, marking a significant milestone in expanding access to minimally invasive robotic technology in China.</li></ul>

Stereotaxis surgical robot gets regulatory nod in China

Discover more